Bleeding time clotting time PT and PTT Dr

Bleeding time, clotting time, PT, and PTT Dr. Ayham Abu Laila

Hemostasis or haemostasis l Is a complex process which causes the bleeding process to stop. l It refers to the process of keeping blood within a damaged blood vessel.

Hemostasis is maintained in the body via three mechanisms : l Vascular spasm - Damaged blood vessels l Platelet plug formation - Platelets adhere to constrict. damaged endothelium to form platelet plug (primary hemostasis) and then degranulate. l Blood coagulation - Clots form upon the conversion of fibrinogen to fibrin, and its addition to the platelet plug (secondary hemostasis).

THE CLOTTING MECHANISM INTRINSIC Collagen EXTRINSC Tisue Thromboplastin XII XI IX VIII VII X FIBRINOGEN (I) V PROTHROMBIN (II) THROMBIN (III) FIBRIN

FIBRINOLYTIC PHASE l ANTICLOTTING MECHANISMS ARE ACTIVATED TO ALLOW CLOT DISINTEGRATION AND REPAIR OF THE DAMAGED VESSEL.

HEMOSTASIS l ¬ ® ¯ ° DEPENDENT UPON: Vessel Wall Integrity Adequate Numbers of Platelets Proper Functioning Platelets Adequate Levels of Clotting Factors Proper Function of Fibrinolytic Pathway

So What Causes Bleeding Disorders? p VESSEL DEFECTS p PLATELET DISORDERS p FACTOR DEFICIENCIES

VESSEL DEFECTS p p p VITAMIN C DEFICIENCY BACTERIAL & VIRAL INFECTIONS ACQUIRED

PLATELET DISORDERS THROMBOCYTOPENIA NUMBER OF PLATELETS) Causes l l DRUG INDUCED BONE MARROW FAILURE HYPERSPLENISM OTHER CAUSES (INADEQUATE

THROMBOCYTOPATHY (ADEQUATE NUMBER BUT ABNORMAL FUNCTION). causes l UREMIA l INHERITED DISORDERS l MYELOPROLIFERATIVE DISORDERS l DRUG INDUCED(ASPIRIN, NSAIDS)

FACTOR DEFICIENCIES l Inherited: 1. HEMOPHILIA A 2. HEMOPHILIA B 3. VON WILLEBRAND’S DISEASE l Acquired: 1. Anticoagulant therapy 2. Liver diseases 3. DIC

LABORATORY EVALUATION l PLATELET COUNT l BLEEDING TIME (BT) l Clotting time (CT) l PROTHROMBIN TIME (PT) l Activated PARTIAL THROMBOPLASTIN TIME (APTT)

PLATELET COUNT (CBC) NORMAL 100, 000 - 400, 000 CELLS/MM 3 < 100, 000 Thrombocytopenia 50, 000 - 100, 000 Mild Thrombocytopenia < 50, 000 Sever Thrombocytopenia

BLEEDING TIME l PROVIDES ASSESSMENT OF PLATELET COUNT AND FUNCTION NORMAL VALUE 2 -8 MINUTES

Clotting time - capillary method Ø Material 1. Sterile disposable pricking needle or lancet. Stop watch Dry glass capillary tube (narrow diameter 1 top 2 mm, minimum 10 cm long. ) Cotton Swab of absorbent cotton. Spirit wetted, cotton swab. 70 % v/v ethyl alcohol 2. 3. 4. 5. 6.

Clotting time of whole blood

Clotting Time - Slide Method • • The surface of the glass tube initiates the clotting process. This test is sensitive to the factors involved in the intrinsic pathway The expected range for clotting time is 4 -10 min.

PROTHROMBIN TIME l Measures Effectiveness of the Extrinsic Pathway NORMAL VALUE 10 -15 SECS

PT l The prothrombin time: is therefore the time required for the plasma to clot after an excess of thromboplastin and an optimal concentration of calcium have been added. l Measures the function of the Extrinsic Pathway. l Sensitive to Factors I, II, V, VII, X. l The PT evaluates patients suspected of having an inherited or acquired deficiency in these pathways.

THE CLOTTING MECHANISM INTRINSIC Collagen EXTRINSC Tisue Thromboplastin XII XI IX VIII VII X FIBRINOGEN (I) V PROTHROMBIN (II) THROMBIN (III) FIBRIN

When is it ordered? l Used to monitor oral anticoagulant therapy (Warfarin / Coumadin). l When a patient who is not taking anti-coagulant drugs has signs or symptoms of a bleeding disorder. l When a patient is to undergo an invasive medical procedure, such as surgery, to ensure normal clotting ability.

An elevated prothrombin time may indicate the presence of: � Vitamin K deficiency (Vitamin K is needed to make prothrombin and other clotting factors) � � Ø Ø Ø DIC liver disease a deficiency in one or more of the following factors: I, II, V, VII, X. Anticoagulant (warfarin)

INR l l A PT test may also be called an INR test. INR (international normalized ratio) stands for a way of standardizing the results of prothrombin time tests, no matter the testing method. So your doctor can understand results in the same way even when they come from different labs and different test methods. Using the INR system, treatment with (anticoagulant therapy) will be the same. In some labs, only the INR is reported and the PT is not reported

l l An INR of 1. 0 means that the patient PT is normal. An INR greater than 1. 0 means the clotting time is elevated. INR of greater than 5 or 5. 5 = unacceptable high risk of bleeding, whereas if the INR=0. 5 then there is a high chance of having a clot. Normal range for a healthy person is 0. 9– 1. 3, and for people on warfarin therapy, 2. 0– 3. 0, although the target INR may be higher in particular situations, such as for those with a mechanical heart valve.

PARTIAL THROMBOPLASTIN TIME l Measures Effectiveness of the Intrinsic Pathway NORMAL VALUE 25 -40 SECS

PTT l The partial thromboplastin time (PTT) or activated partial thromboplastin time (a. PTT or APTT )is a performance indicator measuring the efficacy of both the "intrinsic" and the common coagulation pathways. l It is also used to monitor the treatment effects with heparin a major anticoagulant. l Kaolin cephalin clotting time (Kcc. T) is a historic name for the activated partial thromboplastin time

THE CLOTTING MECHANISM INTRINSIC Collagen EXTRINSC Tisue Thromboplastin XII XI IX VIII VII X FIBRINOGEN (I) V PROTHROMBIN (II) THROMBIN (III) FIBRIN

l Normal PTT times require the presence of the following coagulation factors: I, III, IV, V, VIII, IX, X, XI, & XII

When is it ordered? l When a patient presents with unexplained bleeding or bruising, l It may be ordered as part of a pre-surgical evaluation for bleeding tendencies, l When a patient is on intravenous (IV) or injection heparin therapy, the APTT is ordered at regular intervals to monitor the degree of anticoagulation.

Prolonged APTT may indicate: l use of heparin. l antiphospholipid antibody: especially lupus anticoagulant , which paradoxically increases propensity to thrombosis l coagulation factor deficiency , e. g hemophilia l DIC l Liver disease

THE CLOTTING MECHANISM INTRINSIC Collagen EXTRINSC Tisue Thromboplastin XII XI IX VIII VII X FIBRINOGEN (I) V PROTHROMBIN (II) THROMBIN (III) FIBRIN

FACTOR DEFICIENCIES l Inherited: 1. l Acquired: 1. Anticoagulant therapy 2. Liver diseases 3. DIC HEMOPHILIA A 2. HEMOPHILIA B 3. VON WILLEBRAND’S DISEASE

l HEMOPHILIA A (Classic Hemophilia) l 80 -85% of all Hemophiliacs l. Deficiency of Factor VIII l. Lab Results - Prolonged PTT

l HEMOPHILIA l 10 -15% B (Christmas Disease) of all Hemophiliacs l Deficiency of Factor IX l Lab Test - Prolonged PTT

l VON WILLEBRAND’S DISEASE l Deficiency of VWF & amount of Factor VIII l Factor VIII is bound to v. WF while inactive in circulation; Factor VIII degrades rapidly when not bound to v. WF l Lab Results - Prolonged BT, PTT

ANTICOAGULANTS l l An anticoagulant is a substance that prevents coagulation; that is, it stops blood from clotting This prevents deep vein thrombosis, pulmonar embolism, myocardial infarction and stroke. l 1. 2. ANTICOAGULANTS Coumadins (Vitamin K antagonists) Heparin

Coumadins These oral anticoagulants that antagonize the effects of vitamin K. l Examples include warfarin. It takes at least 48 to 72 hours for the anticoagulant effect to develop. Where an immediate effect is required, heparin must be given concomitantly. l Monitored by PT times l These anticoagulants are used to treat patients with deep-vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), and mechanical prosthetic heart valves. l

Heparin l l Heparin is a biological substance. It works by activating antithrombin III, which blocks thrombin from clotting blood. Heparin Therapy is Monitored by PTT times Low molecular weight heparin is a more highly processed product that is useful as it does not require monitoring of the APTT coagulation parameter (it has more predictable plasma levels) and has fewer side effects.

Liver Disease l Liver Disease can Result in Reduced Production of Coagulation Factors (I, II, V, VII, IX, X).

DIC Disseminated intravascular coagulation) DIC is a pathological activation of coagulation (blood clotting) mechanisms that happens in response to a variety of diseases l DIC leads to the formation of small blood clots inside the blood vessels throughout the body l The small clots also disrupt normal blood flow to organs (such as the kidneys), which may malfunction as a result l

l As the small clots consume coagulation proteins and platelets, normal coagulation is disrupted and abnormal bleeding occurs from the skin the gastrointestinal tract, the respiratory tract and surgical wounds. The PT and APTT are usually very prolonged and the fibrinogen level markedly reduced l High levels of fibrin degradation products, including Ddimer, are found owing to the intense fibrinolytic activity stimulated by the presence of fibrin in the circulation. l

Definitive diagnosis depends on the result of DIC: Thrombocytopenia (prolonged bleeding time) l Prolongation of prothrombin time and activated partial thromboplastin time l A low fibrinogen concentration l Increased levels of fibrin degradation products l

Condition Partial Prothrombi thromboplastin n time Bleeding time Platelet count Von Willebrand disease unaffected prolonged unaffected Vitamin K deficiency or Warfarin prolonged unaffected Uremia unaffected prolonged Haemophilia unaffected prolonged unaffected Factor V deficiency prolonged unaffected Aspirin unaffected prolonged unaffected Thrombocytopenia unaffected prolonged decreased End-stage Liver failure prolonged decreased Disseminated intravascular coagulation prolonged decreased Bernard-Soulier syndrome unaffected prolonged decreased unaffected

THANK YOU